Innovations in group‐based psilocybin‐assisted therapy of major depression in patients with cancer
Johannes Thrul, Zofia Kozak, Michael A. Carducci, Albert Garcia‐romeu, David B. Yaden
Cancer December 18, 2023 DOI: 10.1002/cncr.35127 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Editorial Peer reviewed |
|---|---|
| Topics | Psilocybin Depression |
| Keywords | Cancer Depression economics Mood Distress Psychotherapist Intervention counseling Oncology Clinical psychology Hallucinogen |
| Citations | 5 |
| Key points | Argues that group-based psilocybin-assisted intervention may be a novel therapeutic approach for treating depression in cancer patients. |
Abstract
Several recent studies have investigated psilocybin as a novel therapeutic compound for the treatment of existential distress in patients with cancer, demonstrating persistent, positive effects on mood. This editorial discusses two articles in the current issue of Cancer that report findings of a group‐based psilocybin‐assisted intervention for treatment of depression in patients diagnosed with cancer.
Citations in the library
Cited by 4
- Review of Psilocybin Use for Depression among Cancer Patients after Approval in Oregon Cancers April 27, 2024
- Beyond psychedelics: set and setting in general psychiatric practice. International Review of Psychiatry December 1, 2024
- Hallucinogen-Assisted Psychotherapy for Trauma Disorders: A Bionian Lens. Psychodynamic psychiatry June 1, 2026
- Roland R. Griffiths, psychopharmacology pioneer: Abuse liability, alcohol, nicotine, caffeine, benzodiazepines, and psychedelics. Journal of Psychopharmacology 2026
Cites 17
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Journal of Psychopharmacology November 30, 2016
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Journal of Psychopharmacology November 30, 2016
- Trial of Psilocybin versus Escitalopram for Depression New England Journal of Medicine April 14, 2021
- Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer Archives of General Psychiatry September 7, 2010
- Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression. New England Journal of Medicine November 3, 2022
and 12 more in the library